ClearPoint Neuro Lowers FY2026 Sales Guidance from $54.000M-$60.000M to $52.000M-$56.000M

Benzinga Newsdesk www.benzinga.com Negative 95.7%

Neg 95.7% Neu 0% Pos 0%

ClearPoint Neuro (NASDAQ:CLPT) lowers FY2026 sales outlook from $54.000 million-$60.000 million to $52.000 million-$56.000 million.